Free Trial
OTCMKTS:CXRXF

ADVANZ PHARMA (CXRXF) Stock Price, News & Analysis

ADVANZ PHARMA logo
$17.06 0.00 (0.00%)
As of 06/10/2021

About ADVANZ PHARMA Stock (OTCMKTS:CXRXF)

Key Stats

Today's Range
$17.06
$17.06
50-Day Range
$17.06
$17.06
52-Week Range
$2.13
$18.00
Volume
39 shs
Average Volume
11,851 shs
Market Capitalization
$834.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CXRXF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ADVANZ PHARMA and its competitors with MarketBeat's FREE daily newsletter.

CXRXF Stock News Headlines

PHAT Phathom Pharmaceuticals, Inc.
“Sell Nvidia before earnings”
Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has been chasing the AI giant, Eric says its biggest customers are now its biggest competitors — and that could spell trouble ahead. Instead, he’s urging investors to consider a little-known hardware company that’s already starting to take off. In fact, while Nvidia has slipped over the past 30 days, this “off-the-radar” stock is up 18% — and Eric believes the run is just beginning.tc pixel
See More Headlines

CXRXF Stock Analysis - Frequently Asked Questions

ADVANZ PHARMA's stock was trading at $17.06 on January 1st, 2025. Since then, CXRXF stock has increased by 0.0% and is now trading at $17.06.

Shares of CXRXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:CXRXF
CIK
N/A
Fax
N/A
Employees
429
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$74.86 million
Net Margins
-15.31%
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-4.38%

Debt

Debt-to-Equity Ratio
257.04
Current Ratio
2.39
Quick Ratio
1.61

Sales & Book Value

Annual Sales
$525.58 million
Price / Sales
1.59
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.16 per share
Price / Book
106.63

Miscellaneous

Outstanding Shares
48,913,000
Free Float
N/A
Market Cap
$834.46 million
Optionable
Not Optionable
Beta
N/A

Social Links

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (OTCMKTS:CXRXF) was last updated on 8/24/2025 by MarketBeat.com Staff
From Our Partners